Abstract
Zoo managed cheetahs provide an insurance population for wild cheetahs that are under threat of extinction from habitat loss, lack of prey, competition, pet trade and poaching for skin and bones. Assisted reproductive techniques including artificial insemination, in vitro fertilization, and embryo transfer augment natural breeding programs but rely on good quality semen for best results. It is understood that anesthesia can affect semen characteristics such as ejaculate volume, total sperm count, sperm motility, and incidence of urine contamination. Thus, the aim of this study was to conduct a retrospective analysis of 23 years of data to investigate sperm parameters of semen collected under anesthesia using medetomidine in combination with butorphanol and midazolam or Telazol® alone. Electroejaculation records (Medetomidine, Butorphanol, and Midazolam anesthetized n = 59 ejaculates, from 30 cheetahs, Telazol® anesthetized, n= 169 ejaculates, from 72 cheetahs) were evaluated for incidence of urine contamination. Electroejaculation records (Medetomidine, Butorphanol, and Midazolam anesthetized n = 21 ejaculates, from 17 cheetahs, Telazol® anesthetized, n = 143 ejaculates, from 63 cheetahs) were evaluated for total sperm count, total motility, ejaculate volume, and testicle size. Telazol® treated cheetahs had a numerically higher total sperm count (Median ± SD: 42.58 ± 77.8 × 106 spermatozoa) compared to those treated with medetomidine (Median ± SD: 31.2 ±44.58 × 106 spermatozoa), and a significantly (p < 0.05) higher sperm motility (Median ± SD: 70.0 ± 9.71%) compared to medetomidine (Median ± SD: 53.0 ± 16.41%) treated cheetahs. The findings of this study indicate that medetomidine anesthesia results in significantly lower sperm motility and Telazol® anesthesia results in a higher total sperm count and motility, thus resulting in higher quality ejaculate. This information can aid in the veterinary management of the species when involved in genome resource banking and assisted reproductive technologies.
1 Introduction
The International Union for Conservation of Nature’s Red List classifies cheetahs (Acinonyx jubatus) as a “vulnerable” species due to a declining population size resulting from habitat loss or fragmentation, poaching and/or lack of available prey (). Additionally, cheetahs have experienced significant population bottlenecks with subsequent inbreeding which has resulted in a lack of genetic diversity (; O’Brien et al., 1985; O’Brien et al., 1986; O’Brien et al., 1987; ). To mitigate further loss of genetic diversity, cheetahs are housed under managed care to act as insurance policies for the declining wild populations. Institutions of the Association of Zoos & Aquariums carefully manage breeding as part of the Species Survival Plan® to maximize genetic diversity.
Assisted reproductive techniques (ART) such as artificial insemination (AI) (), in vitro fertilization and embryo transfer () are used to augment breeding programs and aim to ensure that genetically underrepresented individuals reproduce and contribute offspring to the managed population. The cryopreservation and storage of spermatozoa in genome resource banks have provided a repository of genetic material that can be used to genetically manage future cheetah populations (Wildt, 1997). However, cheetah semen has been characterized as having low numbers of morphologically normal spermatozoa and low sperm concentrations (Wildt et al., 1983; ; Terrell et al., 2016). The high incidence of abnormally structured cells makes cheetah spermatozoa highly susceptible to cryo-induced damage (). As a result, the ongoing systematic collection and cryopreservation of spermatozoa is required to support the genetic management of cheetahs through ART.
Semen is collected from cheetahs by a technique known as electroejaculation (EEJ) which requires a surgical plane of anesthesia (). It has been well documented that analgesics can alter sperm function in a range of species (; ; ) including the domestic cat (Zambelli et al., 2007) and have anecdotally been reported to influence the success of the semen collection. In zoos, cheetahs were historically anesthetized with a protocol involving drugs such as Telazol®, ketamine, or xylazine for health examinations (Penfold, personal communication). In recent years, this protocol has changed and medetomidine is the more commonly used anesthetic due to better desired physiological effects such as stable heart rate, respiratory rates, and quick recovery (; Williamson et al., 2018). Therefore, the aim of the present study was to retrospectively investigate the effects of anesthesia protocols using Telazol® and medetomidine on semen characteristics.
2 Materials and methods
2.1 Cheetahs and criteria for data selection
Cheetahs were housed at White Oak Conservation (WOC) in Yulee, Florida from 1998-2021 or at the Cheetah Conservation Fund (CCF) in Namibia from 2002-2005. Captive cheetahs at WOC were fed a diet of commercially available beef, horse, venison, and/or pork meat products (Milliken Meat Products Ltd, or Carnivore Diet 10; Natural Balance Pet Foods Inc., Pacoima, CA) seven days a week, bones one day a week, and supplemented with whole rabbits when available. Wild cheetahs at CCF were fed combination of donkey, horse and game species with mineral supplementation as described previously (; ). Animals had access to ad libitum water. Cheetahs were housed individually or as coalition groups and ranged from one to fifteen years in age. Medical records, stored in Species 360 Zoological Information Management System (ZIMS and reproductive summary reports generated by the South-East Zoo Alliance for Reproduction & Conservation and CCF, were reviewed (228 procedures between the years of 1998 and 2021). Incidence of urine contamination was recorded and compared between the two anesthesia protocols (MBMZ anesthetized n = 59 ejaculates, from 30 cheetahs, Telazol® anesthetized, n= 169 ejaculates, from 72 cheetahs). The effect of age on total sperm count was investigated in each treatment group (MBMZ anesthetized n = 29 ejaculates, from 22 cheetahs, Telazol® anesthetized, n= 162 ejaculates, from 71 cheetahs). To investigate the effect of anesthesia protocols on semen characteristics, ejaculates collected from healthy, sexually mature (≥2 years of age) () males, that were not contaminated with urine, were included in the data analysis (MBMZ anesthetized n = 21 ejaculates, from 17 cheetahs, Telazol® anesthetized, n= 143 ejaculates, from 63 cheetahs).
2.2 Anesthesia
Males were anesthetized using one of two protocols. Protocol 1 utilized a range of 0.030-0.035 mg/kg of Medetomidine, 0.18-0.22 mg/kg of Butorphanol, and 0.10-0.14 mg/kg of Midazolam (MBMZ) in captive WOC cheetahs. Protocol 2 utilized a range of 4 mg/kg to 6 mg/kg of tiletamine hydrochloride plus zolazepam (Telazol®) () in wild CCF cheetahs and two captive WOC cheetahs. While isoflurane gas was used during some cheetah immobilizations, it was not applied until after the EEJ procedure ended.
2.3 Semen collection and characterization
Prior to semen collection, testes were measured with calipers and the total testes volume was calculated (V = L × W2 × 0.524; where V= total volume, L = total length and W = width)14. Investigators conducting semen collections (L.M.P. and A.E.C.) were trained by the same researcher (Dr. Jo-Gayle Howard) and followed the same protocol for semen collection (). In brief, feces were manually removed from the rectum and the prepuce was rinsed with sterile phosphate-buffered saline. The penis was extended from the prepuce and placed in a sterile collection cup (BD Falcon, Franklin Lakes, NJ, USA). To collect the semen, a Teflon rectal probe (1.6 cm in diameter with three longitudinal electrodes) and electro-stimulator were used to administer 10 stimulations at 2, 3 and 4 volts (Series I), 3, 4, 5 volts (Series II), and 5 and 6 volts (Series III) (). Semen was characterized as previously described (; ). Data sheets were reviewed for testicular volume, semen volume, total sperm count, total motility, and presence of urine contamination. In brief, volume was measured using adjustable micropipettes (Pipetman Classic, Gilson Incorporated, Middleton, WI, USA). Sperm concentration was calculated by diluting semen 1:400 with water and counting the number of spermatozoa in a 10 µl volume using a hemocytometer (Daigger Scientific, Inc., Hills, IL, USA). Total sperm count was calculated by multiplying semen volume by the sperm concentration. Sperm motility (%) was subjectively assessed using phase-contrast microscopy (40 ×, Olympus B-Max Microscope, Olumpus Optical Co. Ltd) examining 5 µl aliquot of raw ejaculate at 37°C with a minimum of three separate fields of view examined. The pH was measured using pH indicator strips (EM Science, Gibbstown, NJ, USA). A sample was considered to be contaminated with urine if the pH was <7.5 ().
2.4 Statistical analysis
Statistical analyses were performed using SigmaPlot (V15.0, Systat Software Inc. San Jose, CA, USA). Ejaculate characteristics between anesthesia protocols were analyzed by a one-way ANOVA and nonparametric Kruskal-Wallis Test. Spearman’s correlation was used to evaluate the correlation between testicle size and total sperm count within anesthesia protocols. Incidence of urine contamination between anesthesia protocols was analyzed using a Pearson chi-squared test. Data are reported as the Median ± SD. Data was considered significant if p < 0.05.
3 Results
3.1 Age v. total sperm count
Analysis of n = 29 MBMZ treated ejaculates showed a decline in total sperm count with age (Figure 1A). Three males >10 years of age had a numerically lower total sperm count (mean ± SEM = 1.14 ± 1.21 × 106 spermatozoa) than sexually mature males ≤10 years of age (mean ± SEM = 44.38 ± 9.73 × 106 spermatozoa). Analysis of n = 162 Telazol® treated ejaculates also showed a decline in total sperm count with age (Figure 1B). Three males >10 years of age had a numerically lower total sperm count (mean ± SEM = 32.38 ± 9.69 × 106 spermatozoa) than sexually mature males ≤10 years of age (mean ± SEM = 67.99 ± 6.55 × 106 spermatozoa). These findings contributed to restricting sperm analysis data to sexually mature males ≤10 years of age.
Figure 1
3.2 Effects of anesthesia on semen collection
The incidence of urine contamination was greater (p < 0.001) for cheetahs anesthetized using MBMZ (50.85%) than Telazol® (4.14%). Although treatment groups were not statistically different, a numerically higher total sperm count was observed in cheetahs anesthetized with Telazol® (Median ± SD: 42.58 ± 77.8 × 106 spermatozoa) than MBMZ (Median ± SD: 31.2 ± 44.58 × 106 spermatozoa) (Figure 2). Total motility was significantly (p < 0.05) greater in ejaculates collected using Telazol® (Median ± SD: 70.0 ± 9.71%) than MBMZ (Median ± SD: 53.0 ± 16.41%) (Figure 3). There was a significant difference (p < 0.05) in testes size between both treatment groups (Median ± SD MBMZ: 11.53 ± 5.81 cm3, Median ± SD Telazol®: 9.16 ± 2.9 cm3) (Table 1). Testes size and total sperm count were not correlated in the MBMZ treatment group (p > 0.05; R = 0.086) but were weakly correlated in the Telazol® treatment group (p < 0.05; R = 2.1).
Table 1
| Drug | MBMZ n = 21 | Telazol® n = 143 | ||
|---|---|---|---|---|
| Median ± SD | Mean ± SEM | Median ± SD | Mean ± SEM | |
| Testes Volume (cm3) | 11.53 ± 5.81a | 14.21 ± 1.27 | 9.16 ± 2.9b | 9.62 ± 0.25 |
| Semen Volume (ml) | 1.08 ± 0.93a | 1.21 ± 0.21 | 2.71 ± 1.24b | 2.69 ± 0.1 |
| Total Sperm Count (×106 sperm) | 31.2 ± 44.58b | 44.38 ± 9.73 | 42.58 ± 77.8b | 67.99 ± 6.51 |
| Motility (%) | 53.0 ± 16.41a | 53.35 ± 3.58 | 70.0 ± 9.71b | 72.17 ± 0.81 |
Ejaculation characteristics of cheetahs anesthetized with MBMZ and Telazol®.
Superscripts (a,b) indicate a significant difference (p <0.05). Superscripts (b,b) indicate no significant difference.
Figure 2
Figure 3
4 Discussion
This is the first study to examine the effect of anesthetic drugs on cheetah spermatozoa. The most compelling impact of anesthesia was on sperm motility, with significantly lower motile sperm found in the MBMZ protocol. Although the testes size was larger in cheetahs anesthetized with MBMZ versus Telazol®, and therefore might have been expected to produce more sperm (Olar et al., 1983), the Telazol® treated cheetahs resulted in a greater total sperm count and significantly greater motility. Correlation coefficients reveal that in the MBMZ protocol, testes size was not correlated with total sperm count (p > 0.05; R= 0.086), however, in the Telazol® protocol, testes size and total sperm count were weakly correlated (p < 0.05; R = 2.1). Total sperm count and motility are vital characteristics in determining the quality of sperm samples to be cryopreserved for use in artificial breeding. The incidence of urine contamination was characterized during semen collection and was more commonly observed in the MBMZ protocol.
Medetomidine is an alpha-2-adrenergic agonist commonly used in non-domestic felid anesthesia (). Alpha-2 receptors are found along the male reproductive tract and are required for successful emission and ejaculation (). Studies investigating the effects of medetomidine, dexmedetomidine, or xylazine on the hypothalamic-pituitary axis demonstrated these drugs’ ability to suppress anti-diuretic hormone secretion. Physiologically this limits water re-uptake by the kidneys, leading to increased volume for urination, seen most pronounced with xylazine (Rouch and Kudo, 1996; ; ; Villela et al., 2005; ; Uddin et al., 2021). Additionally, medetomidine targets alpha-2 receptors of smooth muscle in the bladder and urethra, possibly leading to conflicting contractions and urine contamination during semen collection (). Smooth muscle contractions along the male reproductive tract are required to mediate ejaculation, but the reproductive physiology remains complex (). Past studies in domestic species have demonstrated that alpha-2 agonists at higher doses result in increased sperm concentration and motility (), but do not stimulate the accessory glands adequately, resulting in a lower volume of semen (). Incidence of retrograde flow of semen involving alpha-2’s has also been observed (; Zambelli et al., 2007) though positive effects on sperm concentration were noted with alpha-2’s administered at higher doses. Urine contamination, retrograde flow, and low sperm volume can result in poor sperm quality which is problematic for assisted reproductive techniques and genome resource banking.
The other two components of Protocol 1 were butorphanol (an opioid) and midazolam (a benzodiazepine). When used alone for sedation, butorphanol has been associated with high sperm concentration at collection, yet when combined with an alpha-2 agonist and NMDA antagonist, it has shown a decrease in sperm concentration (Ungerfeld et al., 2022). Midazolam is not commonly used as the sole choice for sedation. In a laboratory setting where rats were administered midazolam twice daily for a week, direct epididymal collections resulted in inferior sperm motility compared to collections from rats administered propofol (). A protocol limiting the use of alpha-2 agonists at low doses might be better for semen collection and genome resource banking and remains a future area of research; additional information on the roles opioids and benzodiazepines play in semen collection is also warranted.
In contrast to medetomidine, Telazol® antagonizes N-methyl-D-aspartate (NMDA) receptors to produce anesthetic effects (). Multiple studies of domestic and wild felids anecdotally support the notion that sperm motility has a high mean value when Telazol® was used (; ; ). In one study involving six domestic cats, researchers collected semen via EEJ methods using Telazol® anesthesia resulting in an average sperm motility of 82.1% (). Similarly, semen also was acquired from six male cheetahs using EEJ methods and Telazol®, with an average motility of 75% (). Lastly, in six adult and four young adult Serengeti-Plains lions under the same conditions (using EEJ and Telazol®), the average motility was 89% and 72%, respectively (). In the present study, spermatozoa were 70.0 ± 9.71% motile in ejaculates from cheetahs treated with Telazol®.
A numerical decline in sperm concentration with age was observed. Males over 10 years old produced a lower total sperm count. These findings are in agreement with other studies where a decrease in litter numbers for males greater than or equal to 13 years of age () was seen suggesting lower total sperm count as a possible explanation for a decline in sperm quality.
Qualification of cheetahs and population sites were limitations to this study. As previously stated, the original 228 semen samples did not all qualify for final statistical analysis based on male prepubescence, senescence (; ), urine contamination, or disease. Additionally, data from some cheetahs were not considered due to administration of additional drugs or isoflurane gas during semen collection. Some medical records lacked enough information to include as well. Finally, there was a limitation of unbalanced design in treatment groups between populations, as two captive cheetahs from White Oak Conservation were treated with Telazol® and grouped accordingly. In an attempt to present the most vital information, sample sizes were limited. Moving forward, detailed medical records are essential to retrospective analyses that inform reproductive physiologists and veterinarians on protocols conducive to adequate ejaculate quality. Additionally, the two cheetah populations are functionally different. Though unavoidable in retrospect, differences include rangeland (wild vs. captive), diet (carcass vs. frozen and prepared), and management. A difference in testes size was appreciated statistically between the two populations in this study attributed to these differences. In an earlier study, a difference in semen quality was not observed in captive versus wild populations of cheetahs (Wildt et al., 1987); a difference cannot be determined as our design is unbalanced (animals treated with Telazol® were both captive and wild). To confirm a difference, controlled studies using MBMZ in wild and captive populations are necessary to compare.
The present study emphasizes that anesthetic protocol should be considered when semen collection of genome resource banking is the primary reason for sedation of endangered felid species. The results inform veterinarians and reproductive physiologists of the effects alpha-2 agonists have on semen collection procedures in cheetahs. With the availability of reversible medications paired with alpha-2 agonists and smoother recoveries, it is unlikely that Telazol® will be used in the future, but manipulating dosages for medetomidine could be considered. The retrospective analysis of collections in cheetahs adds to the unique history zoological institutions share in managed breeding and warrants continued research to better existing protocols.
Statements
Data availability statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Ethics statement
Ethical approval was not required for the study involving animals in accordance with the local legislation and institutional requirements because this is a retrospective study on cheetahs.
Author contributions
CB: Conceptualization, Data curation, Investigation, Visualization, Writing – original draft, Writing – review & editing. LP: Conceptualization, Investigation, Methodology, Project administration, Resources, Supervision, Writing – review & editing. JG: Data curation, Formal Analysis, Investigation, Supervision, Writing – original draft, Writing – review & editing. SC: Investigation, Methodology, Resources, Writing – review & editing. LM: Data curation, Investigation, Methodology, Resources, Writing – review & editing. AC: Data curation, Investigation, Methodology, Resources, Writing – review & editing.
Funding
The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.
Acknowledgments
The authors would like to thank White Oak Conservation and the Cheetah Conservation Fund for providing medical records and Jack Kottwitz, DVM, PhD, CertAqV for guidance on pharmacological aspects of the study.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
AgirregoitiaE.ValdiviaA.CarracedoA.CasesL.GilJ.SubiranN.et al. (2006). Expression and localization of δ-, κ-, and μ-opioid receptors in human spermatozoa and implications for sperm motility. J. Clin. Endocrinol. Metab.91 (12), 4969–4975. doi: 10.1210/jc.2006-0599
2
BertschingerH. J.MeltzerD. G. A.van DykA.. (2008). Captive breeding of cheetahs in South Africa 30 years of data from the de wildt cheetah and wildlife centre. Reprod. Domest. Anim.43, 66–73. doi: 10.1111/j.1439-0531.2008.01144.x
3
BrownJ. C.BushM.PackerC.PuseyA. E.MonfortS. L.O’BrienS. J.et al. (1991). Developmental changes in pituitary-gonadal function in free-ranging lions (Panthera leo leo) of the Serengeti Plains and Ngorongoro Crater. Reproduction91 (1), 29–40. doi: 10.1530/jrf.0.0910029
4
CabralA. M.KapustaD. R.KenigsV. A.VarnerK. J. (1998). Central α2-receptor mechanisms contribute to enhanced renal responses during ketamine-xylazine anesthesia. Am. J. Physiol.-Regul. Integr. Comp. Physiol.275 (6), R1867–R1874. doi: 10.1152/ajpregu.1998.275.6.r1867
5
CarrilloA. V.RodriguezM. A.Rodriguez-MartinezH. (2016). The mu (μ) and delta (δ) opioid receptors modulate boar sperm motility. Mol. Reprod. Dev.83 (8), 724–734. doi: 10.1002/mrd.22675
6
CelaleddinS.VolkanK. (2020). The effects of propofol and midazolam on rat spermatogenic parameters. Arquivo Brasileiro Medicina Veterinaria E Zootecnia72 (5), 1727–1730. doi: 10.1590/1678-4162-11909
7
CrosierA. E.PukazhenthiB. S.HenghaliJ. N.HowardJ.DickmanA. J.MarkerL.et al. (2006). Cryopreservation of spermatozoa from wild-born Namibian cheetahs (Acinonyx jubatus) and influence of glycerol on cryosurvival. Cryobiology52 (2), 169–181. doi: 10.1016/j.cryobiol.2005.10.011
8
CrosierA. E.MarkerL.HowardJ.PukazhenthiB. S.HenghaliJ. N.WildtD. E. (2007). Ejaculate traits in the Namibian cheetah (Acinonyx jubatus): influence of age, season and captivity. Reproduction Fertil. Dev.19 (2), 370. doi: 10.1071/rd06057
9
CrosierA. E.LamyJ.BapodraP.RappS.MalyM.JungeR.et al. (2020). First birth of cheetah cubs from in vitro fertilization and embryo transfer. Animals10 (10), 1811. doi: 10.3390/ani10101811
10
Da SilvaM. C. C.UllonyK. M.Ribeiro de AraujoG.Jorge-NetoP. N.AlbuquerqueV. B.CaramalacS. M.et al. (2021). Can detomidine replace medetomidine for pharmacological semen collection in domestic cats? Anim. Reprod.18 (2). doi: 10.1590/1984-3143-ar2021-0017
11
DonoghueA. M.HowardJ.BaroneM. A.GoodroweK. L.BlumerE. S.SnodgrassK.et al. (1992). Successful induction of ovarian activity and laparoscopic intrauterine artificial insemination in the Cheetah (Acinonyx jubatus). J. Zoo Wildlife Med.23 (3), 288–300. Available at: http://www.jstor.org/stable/20095230.
12
DooleyM. P.PinedaM. H.HopperJ. G.HsuW. H. (1990). Retrograde flow of spermatozoa into the urinary bladder of dogs during ejaculation or after sedation with xylazine. PubMed51 (10), 1574–1579.
13
DurrantB. S.MillardS. E.ZimmermanD.LindburgD. G. (2001). Lifetime semen production in a cheetah (Acinonyx jubatus). Zoo Biol.20 (5), 359–366. doi: 10.1002/zoo.1034
14
HowardJ. (1993). “Semen collection and analysis in nondomestic carnivores,” in Zoo and Wildlife Animal Medicine: Current Therapy III. Eds. FowlerM. E.MillerR. E. (Philadelphia, PA: W.B. Saunders Co), 390–399.
15
HowardJ. G.BaroneM. A.DonoghueA. M.WildtD. E. (1992). The effect of pre-ovulatory anaesthesia on ovulation in laparoscopically inseminated domestic cats. Reproduction96 (1), 175–186. doi: 10.1530/jrf.0.0960175
16
IUCN/SSC. (2007). Regional Conservation Strategy for the Cheetah and African Wild Dog in Southern Africa (Gland. Switzerland: IUCN Species Survival Commission).
17
JohnsonW. E.OnoratoD. P.RoelkeM. E.LandE. D.CunninghamM.BeldenR. C.et al. (2010). Genetic restoration of the Florida panther. Science329 (5999), 1641–1645. doi: 10.1126/science.1192891
18
KottwitzJ.StoopsM.ReevesJ.HarmonR.WilbornR.EdmondsonM.et al. (2017). Negative effects of analgesic and anesthetic drugs on sperm motility: implications for assisted breeding in managed rhinoceros. Proc. Am. Assoc. Zoo Vet., 107–108.
19
LesterP. A. (2012). “Anesthesia and analgesia,” in The Laboratory Rabbit, Guinea Pig, Hamster, and Other Rodents. Eds. SuckowM. A.StevensK. A.WilsonR. P. (Boston. Boston: Academic Press), 33–56.
20
LongJ. A.WildtD. E.WolfeB. A.CritserJ. K.DeRossiR. V.HowardJ. (1996). Sperm capacitation and the acrosome reaction are compromised in teratospermic domestic cats1. Biol. Reprod.54 (3), 638–646. doi: 10.1095/biolreprod54.3.638
21
MalyM. A.EdwardsK. L.FarinC. E.KoesterD. C.CrosierA. E. (2018). Assessing puberty in ex situ male cheetahs (Acinonyx jubatus) via fecal hormone metabolites and body weights. Gen. Comp. Endocrinol.268, 22–33. doi: 10.1016/j.ygcen.2018.07.011
22
McCueP. M. (2021). Chemical ejaculation. Equine Reprod. Procedures, 455–456. doi: 10.1002/9781119556015.ch121
23
McDonnellS. M. (1992). Ejaculation: physiology and dysfunction. Vet. Clinics North America-equine Pract.8 (1), 57–70. doi: 10.1016/s0749-0739(17)30466-2
24
Menotti-RaymondM.O’BrienS. J. (1993). Dating the genetic bottleneck of the African cheetah. Proc. Natl. Acad. Sci. U. S. A.90 (8), 3172–3176. doi: 10.1073/pnas.90.8.3172
25
MichelM. C.VrydagW. (2006). α1 -, α2 - and β-adrenoceptors in the urinary bladder, urethra and prostate. Br. J. Pharmacol.147 (S2), S88–S119. doi: 10.1038/sj.bjp.0706619
26
MillerM. A.WeberM.NeifferD.MangoldB.FontenotD.StetterM. (2003). Anesthetic induction of captive tigers (Panthera tigris) using a medetomidine-ketamine combination. J. Zoo Wildlife Med.34 (3), 307–308. doi: 10.1638/02-036
27
MurahataY.HikasaY. (2012). Comparison of the diuretic effects of medetomidine hydrochloride and xylazine hydrochloride in healthy cats. Am. J. Vet. Res.73 (12), 1871–1880. doi: 10.2460/ajvr.73.12.1871
28
NuñezE. E. N.SteffeyE. P.OcampoL.RodriguezA.GarciaA. A. (2004). Effects of α2-adrenergic receptor agonists on urine production in horses deprived of food and water. Am. J. Vet. Res.65 (10), 1342–1346. doi: 10.2460/ajvr.2004.65.1342
29
O’BrienS. J.WildtD. E.GoldmanD.MerrilC. R.BushM. (1983). The cheetah is depauperate in genetic variation. Science221 (4609), 459–462. doi: 10.1126/science.221.4609.459
30
O’BrienS. J.RoelkeM. E.MarkerL.NewmanA.WinklerC. A.MeltzerD.et al. (1985). Genetic basis for species vulnerability in the cheetah. Science227 (4693), 1428–1434. doi: 10.1126/science.2983425
31
O’BrienS. J.RoelkeM. E.MarkerL.NewmanA.WinklerC.A.MeltzerD.et al. (1986). The cheetah in genetic peril. Sci. Am.254 (5), 84–95. doi: 10.1038/scientificamerican0586-84
32
O’BrienS. J.WildtD. E.BushM.CaroT.FitzgibbonC.AggundeyI.et al. (1987). East African cheetahs: evidence for two population bottlenecks? Proc. Natl. Acad. Sci. U. S. A.84 (2), 508–511. doi: 10.1073/pnas.84.2.508
33
OlarT. T.AmannR. P.PickettB. W. (1983). Relationships among testicular size, daily production and output of spermatozoa, and extragonadal spermatozoal reserves of the dog. Biol. Reprod.29 (5), 1114–1120. doi: 10.1095/biolreprod29.5.1114
34
RouchA. J.KudoL. H. (1996). Alpha 2-adrenergic-mediated inhibition of water and urea permeability in the rat IMCD. Am. J. Physiology-renal Physiol.271 (1), F150–F157. doi: 10.1152/ajprenal.1996.271.1.f150
35
TerrellK. A.CrosierA. E.WildtD. E.O’BrienS. J.AnthonyN.MarkerL.et al. (2016). Continued decline in genetic diversity among wild cheetahs (Acinonyx jubatus) without further loss of semen quality. Biol. Conserv.200, 192–199. doi: 10.1016/j.biocon.2016.05.034
36
UddinM.SebastianJ.UsamaM.RaziqF. I.SaydainG.RossiN. F. (2021). Dexmedetomidine induced polyuria in the intensive care unit. Case Rep. Crit. Care2021, 1–3. doi: 10.1155/2021/8850116
37
UngerfeldR.Andrews de Moura FernandesD.Alvarez BalaroM. F.TairaA. R.Gomes de Espirito SantoC.Rodrigues SantosJ. D.et al. (2022). Administration of butorphanol with ketamine/xylazine sedation reduces the negative responses to electroejaculation in rams. Theriogenology191, 96–101. doi: 10.1016/j.theriogenology.2022.08.008
38
VillelaN. R.do Nascimento JuniorP.de CarvalhoL. R.TeixeiraA. (2005). Efeitos da dexmedetomidina sobre o sistema renal e sobre a concentração plasmática do hormônio antidiurético: estudo experimental em cães. Rev. Bras. Anestesiologia55 (4). doi: 10.1590/s0034-70942005000400007
39
WildtD. E. (1997). “Genome resource banking,” in Reproductive Tissue Banking. Eds. KarowA. M.CrtiserJ. K. (New York: Elsevier), 399–439.
40
WildtD. E.BushM.HowardJ. G.O’BrienS. J.MeltzerD.van DykA.et al. (1983). Unique seminal quality in the South African cheetah and a comparative evaluation in the domestic cat. Biol. Reprod.29 (4), 1019–1025. doi: 10.1095/biolreprod29.4.1019
41
WildtD. E.O’BrienS. J.HowardJ. G.CaroT. M.RoelkeM. E.BrownJ. L.et al. (1987). Similarity in Ejaculate-Endocrine characteristics in captive versus Free-Ranging cheetahs of two subspecies1. Biol. Reprod.36 (2), 351–360. doi: 10.1095/biolreprod36.2.351
42
WilliamsonR. H.MullerL. I.BlairC. D. (2018). The use of ketamine-xylazine or butorphanol-azaperone-medetomidine to immobilize American black (Ursus americanus). J. Wildlife Dis.54 (3), 503–510. doi: 10.7589/2017-10-255
43
ZambelliD.CuntoM.PratiF.MerloB. (2007). Effects of ketamine or medetomidine administration on quality of electroejaculated sperm and on sperm flow in the domestic cat. Theriogenology68 (5), 796–803. doi: 10.1016/j.theriogenology.2007.06.008
Summary
Keywords
semen collection, alpha-2 agonists, electroejaculation, genome resource banking, cheetah (Acinonyx jubatus)
Citation
Baquerizo CI, Penfold LM, Gillis JD, Citino S, Marker L and Crosier AE (2023) A retrospective analysis investigating the effects of Telazol® and medetomidine on ejaculate characteristics in cheetahs (Acinonyx jubatus). Front. Conserv. Sci. 4:1293180. doi: 10.3389/fcosc.2023.1293180
Received
12 September 2023
Accepted
09 November 2023
Published
28 November 2023
Volume
4 - 2023
Edited by
José Luis Ros-Santaella, Czech University of Life Sciences Prague, Czechia
Reviewed by
Maitê Cardoso Coelho Da Silva, Federal University of Mato Grosso do Sul, Brazil; Sylwia Prochowska, Wroclaw University of Environmental and Life Sciences, Poland
Updates
Copyright
© 2023 Baquerizo, Penfold, Gillis, Citino, Marker and Crosier.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Carolina I. Baquerizo, cib38@cornell.edu
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.